Drug Profile
Naltalimide - Toray
Alternative Names: TAK-363; TRK-130Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Takeda; Toray
- Class Urologics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Overactive bladder
- Discontinued Urinary frequency; Urinary incontinence
Most Recent Events
- 08 Aug 2019 No development reported - Phase-II for Overactive bladder in Japan (PO)
- 17 May 2016 Chemical information added
- 11 Apr 2005 Preclinical trials in Urinary frequency in USA (unspecified route)